Beclin 2 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Beclin 2 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityBeclin 2
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman; mouse
Isotypen/a
FormatPeptide Affinity purified
Size0.1 mg
Concentration1 mg/ml
ApplicationsWestern Blot (WB), Immunocytochemistry (ICC), Immunofluorescence (IF)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionDetects ~48 kDa. Beclin 2 is a novel coiled-coil protein related to the autophagic Beclin 1 protein. It is thought to interact with Bcl-2, an anti-apoptotic protein, and is believed to function in autophagy. It has alson been found to mediate G protein-coupled receptro (GPCR) degradation (1).
ImmunogenImmunogen: Synthetic peptide from the C-terminal of Mouse Beclin 2 (aa. 410-421). Immunogen Species: Mouse. Cellular Localization: Cytoplasm. Conjugate: Unconjugated. Storage Buffer: PBS, 50% glycerol, 0.09% sodium azide. Tissue Specificity: Expressed in brain, skeletal muscle, placenta, thymus and uterus. Expressed at a lower level in liver, testis, stomach, and 17-day-old embryos.
Other Names[Rabbit Mouse Beclin 2; Becn2; Beclin-2; PFM 2; PR domain zinc finger protein 5; PRDM 5; PRDM5 protein; PR domain-containing protein 5; PRDM5; PFM2; PR domain containing 5; PRDM5_HUMAN; PR domain containing protein 5; BCS2], [Becn2; Becn2; Gm104; Beclin-2]
Gene, Accession #[Becn2], Gene ID: 226720, NCBI: NP_001277621.1, UniProt: P0DM65
Catalog #MBS809400
Price$390
Order / More InfoBeclin 2 Antibody from MYBIOSOURCE INC.
Product Specific References1. He C., et al. (2013) Cell. 154(5): 1085-1099.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.